RAGE antagonist peptide TFA

Name: RAGE antagonist peptide TFA
Brand: MedChemExpress
SKU: HY-P2268A
Rating: 4.5 (2 reviews)

Cat. No.: HY-P2268A Purity: 99.71%: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

RAGE antagonist peptide TFA is an advanced glycation end products (RAGE) antagonist. RAGE antagonist peptide TFA prevents RAGE from binding with several of its most important ligands, including HMGB-1, S100P, and S100A4. RAGE antagonist peptide TFA possesses anti-tumor and anti-inflammatory activities.

For research use only. We do not sell to patients.

Custom Peptide Synthesis

RAGE antagonist peptide TFA Chemical Structure

Size	Price	Stock	Quantity
1 mg	USD 89	In-stock	Estimated Time of Arrival: December 31
5 mg	USD 270	In-stock	Estimated Time of Arrival: December 31
10 mg		Get quote
50 mg		Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 2 publication(s) in Google Scholar

Other Forms of RAGE antagonist peptide TFA:

RAGE antagonist peptide In-stock

2 Publications Citing Use of MCE RAGE antagonist peptide TFA

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description

In Vitro

RAGE antagonist peptide TFA (RAP) reduces the ability of the ligands to stimulate RAGE activation of NFκB in cancer cells in vitro^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

RAGE antagonist peptide TFA (RAP, 100 µg) inhibits RAGE-mediated Basal NFκB Activity in PDAC cells in vivo^[1].
RAGE antagonist peptide TFA (RAP) reduces the growth and metastasis of pancreatic tumors and also inhibited glioma tumor growth^[1].
In mice bearing asthma, RAGE antagonist peptide TFA (RAP; 4 mg/kg; i.p.) blunts airway reactivity, airway inflammation and goblet cell metaplasia, and decreases release of Th2 cytokines. RAGE antagonist peptide TFA also reduces total, cytoplasmic and nuclear levels of β-catenin, enhances β-catenin phosphorylation at Ser33/37/Thr41, which triggers ubiquitination, down-regulated expression of β-catenin targeted genes, and tends to keep β-catenin at the cytomembrane, shifting β-catenin from a signalling active pattern to an adhesive function^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Cancer cells expressing the NFκB-luc reporter implanted into immune-deficient mice^[1].
Dosage:	100 µg
Administration:	Intratumoral delivery (or intraperitoneally).
Result:	Systemic administration caused a substantial reduction (p<0.05) in the NFκB signal 5 h after injection.

Molecular Weight

1386.58

Formula

C₅₉H₁₀₂F₃N₁₃O₁₉S

Appearance

Solid

Color

White to off-white

Sequence Shortening

Ac-ELKVLMEKEL-NH2

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Sealed storage, away from moisture

Powder	-80°C	2 years
	-20°C	1 year

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Solvent & Solubility

In Vitro:

DMSO : ≥ 50 mg/mL (36.06 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

H₂O : 14.29 mg/mL (10.31 mM; Need ultrasonic)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	0.7212 mL	3.6060 mL	7.2120 mL
5 mM	0.1442 mL	0.7212 mL	1.4424 mL
10 mM	0.0721 mL	0.3606 mL	0.7212 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Calculation results:

Working solution concentration: mg/mL

Purity & Documentation

Purity: 99.71%

Select Batch:

Data Sheet (271 KB) SDS (251 KB)

COA (241 KB) LCMS (116 KB) Elemental Analysis Report (100 KB)

Handling Instructions (2659 KB)

References

[1]. Thiruvengadam Arumugam, et al. S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis. Clin Cancer Res. 2012 Aug 15;18(16):4356-64. [Content Brief]

[2]. Lihong Yao, et al. The receptor for advanced glycation end products is required for β-catenin stabilization in a chemical-induced asthma model. Br J Pharmacol. 2016 Sep;173(17):2600-13. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

H₂O / DMSO	1 mM	0.7212 mL	3.6060 mL	7.2120 mL	18.0300 mL
	5 mM	0.1442 mL	0.7212 mL	1.4424 mL	3.6060 mL
	10 mM	0.0721 mL	0.3606 mL	0.7212 mL	1.8030 mL
DMSO	15 mM	0.0481 mL	0.2404 mL	0.4808 mL	1.2020 mL
	20 mM	0.0361 mL	0.1803 mL	0.3606 mL	0.9015 mL
	25 mM	0.0288 mL	0.1442 mL	0.2885 mL	0.7212 mL
	30 mM	0.0240 mL	0.1202 mL	0.2404 mL	0.6010 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.